Our data indicate that obesity, even without manifest insulin resistance, predisposes to enhanced atherosclerosis and increased oxidative stress, in which chemerin functions as a potential modulator of inflammation and oxidant/antioxidant status. This evidence concerns the gene RARRES2 and Insulin resistance.